Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05071274 · ClinicalTrials.gov registry record · NA
A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45
A NA study, sponsored by Crown Laboratories.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05071274 is a NA study that has completed, run by Crown Laboratories. The registered enrollment target is 31 participants.
The verdict
NCT05071274, a NA study, has completed, sponsored by Crown Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This single-center, proof of concept trial is being conducted over the course of 42 days followed by a 2-month post-last treatment visit in order to assess the efficacy and tolerability of the Sponsor's SkinPen device in treating Acne Vulgaris on the face.
Interventions
- DEVICE Skinpen Prescision System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2022-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05071274
The ClinicalTrials.gov registry entry for NCT05071274 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Crown Laboratories, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Skinpen Prescision System is the first listed.
NCT05071274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05071274 about?
NCT05071274 is a clinical study titled "A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45". This single-center, proof of concept trial is being conducted over the course of 42 days followed by a 2-month post-last treatment visit in order to assess the efficacy and tolerability of the Sponsor's SkinPen device in treating Acne Vulgaris on the face.
What is the current status of trial NCT05071274?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-03-15. Estimated completion is 2022-03-18.
What interventions are being tested in trial NCT05071274?
The interventions under investigation include: Skinpen Prescision System (DEVICE).
Who is sponsoring clinical trial NCT05071274?
This trial is sponsored by Crown Laboratories, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.